Alexandra Petiet1,2, Mathieu Santin1,2, Elodie Laffrat2, Romain Valabrègue1,2, Thomas Samoyeau2, Stéphane Hunot2, and Stéphane Lehéricy1,2
1Center for Neuroimaging Research, Brain and Spine Institute, Paris, France, 2CNRS UMR 7225/INSERM 1127/UPMC UM75, Brain and Spine Institute, Paris, France
Synopsis
Parkinson’s disease (PD) is
characterized by neurodegeneration of the dopaminergic neurons in the substantia
nigra pars compacta (SNc). The 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
(MPTP) neurotoxin can induce Parkinson syndrome in primate models. We evaluated
the nigrostriatal (NS) pathway degeneration in MPTP Squirrel monkeys using
diffusion MRI. The results showed significantly increased fractional anisotropy
in all NS regions of the MPTP group (SN, caudate and putamen regions). Axial
diffusivity also significantly increased in the SN and caudate regions, while
radial diffusivities did not show any differences, except a significantly
decreased λ3 in the putamen. Those results should help develop
preclinical evaluation of PD therapeutics.
PURPOSE
Parkinson’s disease
(PD) is characterized by neurodegeneration of the dopaminergic neurons in the
substantia nigra pars compacta (SNc). MRI has been used to study
neurodegeneration in the nigro-striatal (NS) system in humans and in animal
models. Exposure to the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)
neurotoxin can induce Parkinson syndrome in non-human primate models1.
Here we sought to evaluate NS pathway injury
using diffusion MRI metrics. We hypothesized that MPTP would induce structural
alterations of water diffusion in the NS system of treated animals.METHODS
Six adult female
squirrel monkeys (saimiri sciureus) were intoxicated with MPTP by repeated
intramuscular injections every 3-4 days during 2 months at a cumulative dose of
17.25 to 25.75 mg/kg. Behavioral motor
alterations were determined using a clinical rating scale consisting of 5 items
including: (1) spatial hypokinesia; (2) body bradykinesia; (3) manual
dexterity; (4) feeding; and (5) tremor. Each item had a score of 0-4 resulting
in a maximum motor score deficit of 20 points. Brain imaging was performed at the following timepoints:
before intoxication, right after the last MPTP injection, 3, 6, 9 and 12 months
after intoxication. We used an ultra-high field MRI system at 11.7T (Bruker
Biospec 117/16 USR horizontal bore, 750mT/m gradients, Paravision 6.0.1,
Ettlingen, Germany) with a custom-built 68-mm diameter transreceive quadrature
coil (MRITools GmbH, Germany). All animals were anesthetized with Alfaxalone
continuous intravenous infusion. Local first and second order shimming was
performed using a Bruker MAPSHIM macro based on a fieldmap acquisition. Anatomical
T2-weighted (T2w) images were acquired with a multi-slice
multi-echo (MSME) sequence; TR=5000ms; TE=13.5ms; Matrix (Mtx)=256x256;
field-of-view (FOV)=5.12x5.12cm2; resolution(res)=200x200μm2; slice thickness=400μm; 128 slices; number of excitations (Nex)=2;
acquisition time (Tacq)=42min. For diffusion imaging, a 3D EPI-based sequence
was used with TR=300ms; TE=18.5ms; Mtx=160x128x88; FOV=6.4x5.12x3.52cm3; res=400μm
isotropic; δ=2.5ms; Δ=8.6ms b-value=1000s/mm2; 80 directions;
Tacq=1h17min. A fieldmap acquisition was used to correct EPI geometric
distortions. DWI data were preprocessed with
standard tools of fsl 5.07: eddy_cor for eddy current correction and fugue for
epi distortion correction with the field map acquisition. We then used dtifit
to compute the tensor metrics. T2w brain template was created
from the 11 individual images. Diffusion images were coregistered to our
template by combining linear transformation of diffusion images to the
individual T2w and a non-linear transformation of the individual T2w
to our T2 template. A total of 11 data points were included in the
analysis to compare the MPTP intoxicated condition with the non-intoxicated
condition (n=2-3 animals / timepoint). The mean values corresponded to averaged
timepoints. Regions of interest (ROI) were manually drawn on our template in
the SN, caudate, and putamen. Those regions included both hemispheres. Finally,
averaged fractional anisotropy (FA) and eigenvalues (λ1, λ2 and λ3) were calculated
within each ROI for each monkey. Group differences between the MPTP and control
groups were tested by using non-parametric Kruskall-Wallis rank test and
considered significant if p<0.05.RESULTS
FA measurements
showed significantly increased FA in all NS regions of the MPTP group compared
to the control group (ctrl) (Figure 1a). Axial diffusivity (λ1) also significantly
increased in the SN and caudate regions (Figure 1b), while radial diffusivities
did not show any differences, except a significantly decreased λ3 in the putamen (not
shown). After MPTP injections, the
squirrel monkeys display a strong parkinsonian syndrome. While clinical
severity increased significantly after the month-period of MPTP exposure
relative to the control group (CTL; i.e. before injection), the scores decreased
one month after cessation of MPTP injections. After 3 months, diseased animals
did not seem to recover further showing behavioral stabilization (Figure 2a).
FA and λ1 time series paralleled behavioral
scores (Figure 2b) with increased values right after injection then decreased
values 3 months later.DISCUSSION AND CONCLUSION
Our results showed
significant increases of diffusion metrics in the NS system of MPTP squirrel
monkeys suggesting neurodegeneration. Our findings are in accordance with those
reported before by Hikishima et al. (2015)2 in MPTP-treated
Marmosets. Furthermore, these changes were correlated to the clinical scores of
the animals over the duration of 3 months. Overall, this work shows the
potential for using diffusion MRI to quantify neurodegeneration in the MPTP
squirrel monkey model and should provide tools for preclinical evaluation of PD
therapeutics.Acknowledgements
The
research leading to these results received funding from the programs “Institut
des Neurosciences Translationnelles” ANR-10-IAIHU-06 and “Infrastructure d’Avenir
en Biologie Santé” ANR-11-INBS-0006.References
1. Gerlach M and Riederer P. Animal models of
Parkinson’s disease: an empirical comparison with the phenomenology of the
disease in man. J Neural Transm 1996;103(8-9):987–1041. 2. Hikishima K, Ando K, Yano R et al. Parkinson Disease:
Diffusion MR Imaging to Detect Nigrostriatal Pathway Loss in a Marmoset Model
Treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Radiology 2015;275(2):430-437.